Treating comorbidities ME/CFS displays an overlap with several autoimmune or immune-mediated diseases that also have chronic fatigue as a main symptom, such as Hashimotos thyroiditis (530), fibromyalgia (FM) (532, 554557), Mast Cell Activation Disorder (532), sleep apnoea (532), IBS (532), secondary depression or anxiety (532), Ehlers-Danlos syndrome (532), and PoTS (532, 558563)
If you have any concerns or underlying health conditions, it is always a good idea to speak with your doctor before starting a new routine.
Plus, we offer continuous communication to address questions and adjust your plan as needed, ensuring you stay on track toward achieving your goals.
Selank is administered intranasally at typical research doses of 250-500 mcg per day, divided into 2-3 administrations
Clinical Evidence Comparison Cerebrolysin: Extensive Clinical Research Base Cerebrolysin has one of the most extensive clinical research bases of any neurotrophic agent, spanning more than three decades of human studies: Alzheimer's Disease Meta-Analysis: Gauthier et al